Concurrent Use of Oral Anticoagulants and Sulfonylureas in Individuals With Type 2 Diabetes and Risk of Hypoglycemia: A UK Population-Based Cohort Study

Concurrent Use of Oral Anticoagulants and Sulfonylureas in Individuals With Type 2 Diabetes and Risk of Hypoglycemia: A UK Population-Based Cohort Study

ObjectiveTo investigate the association of concurrent use of oral anticoagulants (OACs) and sulfonylureas and the risk of hypoglycemia in individuals with type 2 diabetes mellitus (T2DM).Research Design and MethodsA retrospective cohort study was conducted between 2001 and 2017 using electronic prim...

Full description

Bibliographic Details
Main Authors: Hassan Alwafi, Ian C. K. Wong, Abdallah Y. Naser, Amitava Banerjee, Pajaree Mongkhon, Cate Whittlesea, Alaa Alsharif, Li Wei
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Medicine
Subjects:
oral anticoagulants
hypoglycemia
sulfonylureas
diabetes mellitus
United Kingdom
drug-drug interactions
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.893080/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.893080/full

Similar Items